Understanding Your ROI

John Elliott from Carevive delves into the pressing question of ROI in the evolving landscape of value-based care reimbursement models. As the oncology care model (OCM) transitions into the enhancing oncology model, stakeholders are evaluating the technology, processes, and resources that will support their future endeavors.

Carevive proves to be a twofold solution, seamlessly aligning with the current fee-for-service model for chronic care management. By providing tools and solutions to manage symptoms, Carevive aids in avoiding hospitalizations and enhancing patient outcomes, leading to additional revenue and reimbursements for partners.

Moreover, Carevive is firmly positioned to align with the future enhanced oncology model, as it focuses on driving transformation, quality metrics, and health equity advancement. The integration of electronic patient-reported outcomes (ePROs) exemplifies Carevive’s commitment to symptom remote management, a vital component of the future model.

Recent Episodes

As hospitals look beyond the ICU to improve outcomes across the entire continuum of care, a key question emerges: how do you expand patient monitoring without overwhelming clinicians with more alarms, more noise, and more work? This episode—part three of a five-part Health and Life Sciences at the Edge series exploring The Future of…

As healthcare systems worldwide face rising costs, workforce shortages, and increasing pressure to balance quality with financial sustainability, traditional classroom-based management education is struggling to keep pace. According to the World Economic Forum, healthcare spending now accounts for nearly 10% of global GDP, making leadership decision-making more consequential—and more complex—than ever. At the same…

Sterile Processing Departments (SPDs) remain the backbone of safe surgical care, yet across the country, they’re still routinely left out of early decision-making around products, construction, staffing, and case planning. As hospitals juggle tighter margins, higher patient acuity, and growing procedural demands, the consequences of excluding SPD voices become unmistakably real—showing up in daily…